Mara Taraborelli

Italian rheumatologist

Mara Taraborelli is …
instance of (P31):
humanQ5

External links are
P1960Google Scholar author IDOUyEpKQAAAAJ
P11718OPENBS author ID02527
P496ORCID iD0000-0003-4214-9033

P27country of citizenshipItalyQ38
P69educated atUniversity of PaviaQ219317
P734family nameTaraborelliQ36897390
TaraborelliQ36897390
TaraborelliQ36897390
P101field of workrheumatologyQ327657
P735given nameMaraQ1528582
MaraQ1528582
P1412languages spoken, written or signedItalianQ652
P106occupationresearcherQ1650915
P21sex or genderfemaleQ6581072

Reverse relations

author (P50)
Q40128412A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies
Q51047575Anti-IFI16 antibodies and their relation to disease characteristics in systemic lupus erythematosus.
Q36245898Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis
Q63581850Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease?
Q37455366Antiphospholipid antibodies and malignancies
Q63581739Antiphospholipid syndrome
Q40282529Are the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) and the undifferentiated connective tissue disease (UCTD) related to each other? A case-control study of environmental exposures
Q41749537Aseptic meningitis occurring during anti-TNF-alpha therapy in rheumatoid arthritis and ankylosing spondylitis
Q44425363Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study
Q47564415Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events
Q39608521Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome
Q40188551Longterm Outcome of Patients with Primary Antiphospholipid Syndrome: A Retrospective Multicenter Study
Q89431702Macrophage activation syndrome in adult systemic lupus erythematosus: report of seven adult cases from a single Italian rheumatology center
Q53256879Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies.
Q44278878Methylenetetrahydrofolate reductase polymorphisms and methotrexate: no association with response to therapy nor with drug-related adverse events in an Italian population of rheumatic patients
Q37994272Much more than thrombosis and pregnancy loss: the antiphospholipid syndrome as a 'systemic disease'.
Q48663436Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years
Q51112781Patients with longstanding primary antiphospholipid syndrome: retrospective analysis of organ damage and mortality.
Q37778891Pregnancy in autoimmune rheumatic diseases: the importance of counselling for old and new challenges
Q38967261Pregnancy-Related Challenges in Systemic Autoimmune Diseases
Q45545338Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositis
Q59130777Primary Biliary Cirrhosis-related Autoantibodies in a Large Cohort of Italian Patients with Systemic Sclerosis
Q63581794Rare autoantibodies to cellular antigens in systemic lupus erythematosus
Q90876627Relationship between endothelial dysfunction, videocapillaroscopy and circulating CD3+CD31+CXCR4+ lymphocytes in systemic lupus erythematosus without cardiovascular risk factors
Q63581762Severe skin involvement in type II cryoglobulinemia successfully treated with thalidomide
Q93360335Systemic Lupus Erythematosus and Endothelial Dysfunction: A Close Relationship
Q48854142The contribution of antiphospholipid antibodies to organ damage in systemic lupus erythematosus.
Q51258128The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus.
Q63581754Treatment and functional outcome of patients with cystoid macular edema: a single-center experience
Q45919294[Methylenetetrahydrofolate reductase polymorphisms in methotrexate treatment of rheumatoid arthritis patients. Review of the literature and personal experience.]

Search more.